WO2001091700A8 - Composition et procede destine a ameliorer l'elasticite des tissus - Google Patents

Composition et procede destine a ameliorer l'elasticite des tissus

Info

Publication number
WO2001091700A8
WO2001091700A8 PCT/US2001/017384 US0117384W WO0191700A8 WO 2001091700 A8 WO2001091700 A8 WO 2001091700A8 US 0117384 W US0117384 W US 0117384W WO 0191700 A8 WO0191700 A8 WO 0191700A8
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
composition
enhancing elasticity
enhancing
elasticity
Prior art date
Application number
PCT/US2001/017384
Other languages
English (en)
Other versions
WO2001091700A2 (fr
Inventor
Thomas F Mitts
Lawrence B Sandberg
Felipe Jimenez Jr
Original Assignee
Connective Tissue Imagineering
Thomas F Mitts
Lawrence B Sandberg
Felipe Jimenez Jr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/584,001 external-priority patent/US6506731B1/en
Priority claimed from US09/580,156 external-priority patent/US6962904B1/en
Priority claimed from US09/580,893 external-priority patent/US6794362B1/en
Priority claimed from US09/580,110 external-priority patent/US6809075B1/en
Priority to AU7501801A priority Critical patent/AU7501801A/xx
Priority to IL15368701A priority patent/IL153687A0/xx
Application filed by Connective Tissue Imagineering, Thomas F Mitts, Lawrence B Sandberg, Felipe Jimenez Jr filed Critical Connective Tissue Imagineering
Priority to EP01941684A priority patent/EP1392346A4/fr
Priority to AU2001275018A priority patent/AU2001275018B2/en
Priority to CA002415225A priority patent/CA2415225A1/fr
Priority to NZ523403A priority patent/NZ523403A/en
Publication of WO2001091700A2 publication Critical patent/WO2001091700A2/fr
Priority to NO20030454A priority patent/NO20030454L/no
Publication of WO2001091700A8 publication Critical patent/WO2001091700A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PCT/US2001/017384 2000-05-30 2001-05-30 Composition et procede destine a ameliorer l'elasticite des tissus WO2001091700A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
NZ523403A NZ523403A (en) 2000-05-30 2001-05-30 Compounds that increase tissue elasticity and turgor which are analogous to portions of elastin
CA002415225A CA2415225A1 (fr) 2000-05-30 2001-05-30 Composition et procede destine a ameliorer l'elasticite des tissus
AU2001275018A AU2001275018B2 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
EP01941684A EP1392346A4 (fr) 2000-05-30 2001-05-30 Composition et procede destine a ameliorer l'elasticite des tissus
IL15368701A IL153687A0 (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
AU7501801A AU7501801A (en) 2000-05-30 2001-05-30 Composition and method for enhancing elasticity of tissue
NO20030454A NO20030454L (no) 2000-05-30 2003-01-29 Sammensetning og fremgangsmåte for å forsterke elastisiteten til vev

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US09/580,893 2000-05-30
US09/580,156 2000-05-30
US09/580,110 2000-05-30
US09/584,001 2000-05-30
US09/584,001 US6506731B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and methods of using same
US09/580,110 US6809075B1 (en) 2000-05-30 2000-05-30 Elastin peptide analogs and uses of same incombination with skin enhancing agents
US09/580,893 US6794362B1 (en) 2000-05-30 2000-05-30 Asparagine containing elastin peptide analogs
US09/580,156 US6962904B1 (en) 1998-03-13 2000-05-30 Elastin peptide analogs and uses thereof

Publications (2)

Publication Number Publication Date
WO2001091700A2 WO2001091700A2 (fr) 2001-12-06
WO2001091700A8 true WO2001091700A8 (fr) 2003-11-20

Family

ID=27504943

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/017384 WO2001091700A2 (fr) 2000-05-30 2001-05-30 Composition et procede destine a ameliorer l'elasticite des tissus

Country Status (7)

Country Link
EP (1) EP1392346A4 (fr)
AU (2) AU2001275018B2 (fr)
CA (1) CA2415225A1 (fr)
IL (1) IL153687A0 (fr)
NO (1) NO20030454L (fr)
NZ (1) NZ523403A (fr)
WO (1) WO2001091700A2 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827170B1 (fr) * 2001-07-13 2004-07-16 Soc Extraction Principes Actif Utilisation de peptides pour augmenter l'adhesion cellulaire
KR20050033512A (ko) * 2001-10-05 2005-04-12 프로사이트 코포레이션 펩타이드 구리 착물 및 레티놀, 레티놀 유도체 또는이들의 혼합물을 함유하는 피부 보호 조성물
EP1434563A1 (fr) * 2001-10-05 2004-07-07 Procyte Corporation Procedes de traitement de l'hyperpigmentation de la peau
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
DE10260928A1 (de) * 2002-12-20 2004-07-08 Henkel Kgaa Verfahren zur Bestimmung von Markern humaner Gesichtshaut
US6927205B2 (en) 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
FR2854897B1 (fr) * 2003-05-12 2007-05-04 Sederma Sa Compositions cosmetiques ou dermopharmaceutiques pour reduire les signes du vieillissement cutane.
WO2006004787A1 (fr) * 2004-06-28 2006-01-12 Procyte Corporation Procédés et composition pour la prévention et le traitement de l’hyperpigmentation de la peau
US20090111758A1 (en) 2006-05-15 2009-04-30 Valio Ltd. Use of therapeutically useful peptides
WO2008100789A2 (fr) 2007-02-16 2008-08-21 Benaroya Research Institute At Virginia Mason Compositions et procédés pour modifier l'élastogenèse
CA2827029C (fr) 2011-02-11 2019-07-02 The Regents Of The University Of Michigan Compositions peptidiques et procedes de traitement de patients
EP2691539B1 (fr) 2011-03-31 2018-04-25 The Procter and Gamble Company Methodes pour l'identification et l'evaluation de principes actifs sur la peau efficaces dans le traitement des pellicules
US9920357B2 (en) 2012-06-06 2018-03-20 The Procter & Gamble Company Systems and methods for identifying cosmetic agents for hair/scalp care compositions
FR3116273B1 (fr) * 2020-11-17 2023-10-27 Sederma Sa Tétrapeptides, compositions les comprenant et leur utilisation cosmétique
KR102484277B1 (ko) * 2021-11-22 2023-01-04 대한켐텍 주식회사 피부 미용 개선용 원료 조성물의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
DE19715103A1 (de) * 1997-04-11 1998-10-15 Targor Gmbh Metallocen-Aminosäure- und Peptid-Komplexe
CA2287254A1 (fr) * 1997-04-21 1998-10-29 Schering Corporation Cytokines de mammifere; reactifs et procedes connexes
US6069129A (en) * 1998-03-13 2000-05-30 Mrs, Llc Elastin derived composition and method of using same
CA2317919A1 (fr) * 1998-11-19 2000-05-25 Connective Tissue Imagineering Llc Utilisation cosmetique ou dermatologique de steroides 7-hydroxylates seuls ou combines ave des peptides derives de l'elastine
EP2275553B1 (fr) * 1999-10-29 2015-05-13 Novartis Vaccines and Diagnostics S.r.l. Peptides antigéniques de Neisseria

Also Published As

Publication number Publication date
AU7501801A (en) 2001-12-11
IL153687A0 (en) 2003-07-06
NO20030454D0 (no) 2003-01-29
NO20030454L (no) 2003-01-29
WO2001091700A2 (fr) 2001-12-06
NZ523403A (en) 2005-04-29
AU2001275018B2 (en) 2008-04-03
EP1392346A2 (fr) 2004-03-03
CA2415225A1 (fr) 2001-12-06
EP1392346A4 (fr) 2006-10-25

Similar Documents

Publication Publication Date Title
EP1157707B8 (fr) Composition et procédé pour la déformation de tissus mous
AU2002230831A1 (en) Compositions of human proteins and method of use thereof
AU2001249967A1 (en) Composition and methods for tissue preservation
AUPR638101A0 (en) Composition and method for treatment of disease
AU2002241228A1 (en) Method and composition for treatment of skeletal dysplasias
AU2001270943A1 (en) Surgical instrument and method of using the same
AU2001271530A1 (en) Method of hard tissue repair
AU2001233081A1 (en) Composition for treatment of stress
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
WO2001091700A8 (fr) Composition et procede destine a ameliorer l'elasticite des tissus
AU2001271031A1 (en) Cosmetic compositions for reducing and method of using the same
AU5800399A (en) Polish composition and method of use
AU2001274181A1 (en) Composition and method for biocide treatment of surfaces
AU2001286983A1 (en) Method of treatment
AU2001233932A1 (en) Method and composition
AU2001234831A1 (en) Magnetoliposome composition for targeted treatment of biological tissue and associated methods
AU2962400A (en) Cleaner composition and method of use thereof
AU2001288291A1 (en) Paving and sealing composition and method of use
AU2003282593A1 (en) Polyphenolamine composition and method of use
AU4839100A (en) Methods of using and compositions comprising n-desmethylzolpidem
AU2001262177A1 (en) Method of treatment
AU2002239775A1 (en) Chemical-library composition and method
AU2001253469A1 (en) Compositions and methods for stabilizing modified tissue
AU2001249194A1 (en) Immunokine composition and method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 153687

Country of ref document: IL

WWE Wipo information: entry into national phase

Ref document number: 2001941684

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001275018

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 523403

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 2415225

Country of ref document: CA

D17 Declaration under article 17(2)a
WWP Wipo information: published in national office

Ref document number: 2001941684

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWP Wipo information: published in national office

Ref document number: 523403

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 523403

Country of ref document: NZ